Skip to main content
Breast Cancer ICYMI
FULL MENU
FULL MENU
Presented by
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
News
Will 100% coverage spur more use of breast cancer chemopreventives?
Publish date:
January 22, 2014
On Twitter
@aliciaault
Pages
« first
1
2
Recommended Reading
Add-on agents boost neoadjuvant chemo response in triple-negative disease
Breast Cancer ICYMI
Breast MRI screening finds undetected cancers in 11 per 1,000 average-risk women
Breast Cancer ICYMI
Findings set stage for immunomodulatory approaches in breast cancer
Breast Cancer ICYMI
Exercise protects black women against ER-negative breast cancer
Breast Cancer ICYMI
Primary care screening advised to select women for BRCA counseling
Breast Cancer ICYMI
Novel treatment promising for chronic neuropathic postmastectomy pain
Breast Cancer ICYMI
No overall benefit seen with bisphosphonate treatment in chemoresistant breast cancer
Breast Cancer ICYMI
Survival no better after primary tumor removal in metastatic breast cancer
Breast Cancer ICYMI
Extracorporeal shock wave therapy promising for lymphedema
Breast Cancer ICYMI
ACA now covers preventive medicine for women at increased risk for breast cancer
Breast Cancer ICYMI
Breast Cancer
FULL MENU
FULL MENU
Presented by
FULL MENU
FULL MENU
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge
Clinical Edge Journal Scan
Clinical Topics
Conference Coverage
Expert Perspectives
MD-IQ
More
MDedge